12,303 Dolby Laboratories $DLB Shares Bought by Vest Financial LLC

Vest Financial LLC boosted its holdings in Dolby Laboratories (NYSE:DLB) by 9.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 136,282 shares of the electronics maker’s stock after buying an additional 12,303 shares during the period. Vest Financial LLC’s holdings in Dolby Laboratories were worth $8,009,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Nisa Investment Advisors LLC grew its stake in shares of Dolby Laboratories by 130.1% in the third quarter. Nisa Investment Advisors LLC now owns 1,452 shares of the electronics maker’s stock worth $85,000 after acquiring an additional 821 shares during the last quarter. Willis Investment Counsel increased its position in Dolby Laboratories by 7.2% during the third quarter. Willis Investment Counsel now owns 42,726 shares of the electronics maker’s stock worth $2,511,000 after acquiring an additional 2,872 shares during the period. Frank Rimerman Advisors LLC increased its position in Dolby Laboratories by 2.7% during the third quarter. Frank Rimerman Advisors LLC now owns 8,403 shares of the electronics maker’s stock worth $494,000 after acquiring an additional 223 shares during the period. Mitchell & Pahl Private Wealth LLC raised its stake in Dolby Laboratories by 8.3% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 18,393 shares of the electronics maker’s stock valued at $1,081,000 after purchasing an additional 1,416 shares during the last quarter. Finally, CX Institutional raised its stake in Dolby Laboratories by 2.7% during the 3rd quarter. CX Institutional now owns 13,074 shares of the electronics maker’s stock valued at $768,000 after purchasing an additional 347 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Dolby Laboratories

In other news, SVP John Couling sold 7,667 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $60.00, for a total value of $460,020.00. Following the completion of the transaction, the senior vice president directly owned 118,727 shares of the company’s stock, valued at approximately $7,123,620. This represents a 6.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $62.71, for a total value of $188,130.00. Following the completion of the sale, the senior vice president directly owned 73,274 shares in the company, valued at approximately $4,595,012.54. This represents a 3.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 28,889 shares of company stock valued at $1,749,388. Corporate insiders own 37.93% of the company’s stock.

Dolby Laboratories Stock Up 1.2%

NYSE DLB opened at $63.24 on Friday. The stock has a market cap of $5.92 billion, a P/E ratio of 26.91 and a beta of 0.78. The company’s 50-day simple moving average is $60.75 and its 200 day simple moving average is $57.61. Dolby Laboratories has a twelve month low of $48.26 and a twelve month high of $69.95.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.02. The firm had revenue of $305.00 million during the quarter, compared to analyst estimates of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Research analysts anticipate that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories announced that its Board of Directors has approved a stock buyback plan on Thursday, July 30th that permits the company to buy back $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to repurchase up to 7% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. The ex-dividend date was Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio is currently 61.28%.

Analyst Upgrades and Downgrades

DLB has been the subject of a number of research reports. Zacks Research downgraded shares of Dolby Laboratories from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, August 28th. Finally, Weiss Ratings raised shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Dolby Laboratories presently has an average rating of “Hold” and an average price target of $87.50.

About Dolby Laboratories

Dolby Laboratories, Inc develops audio and imaging technologies used to enhance entertainment and communications experiences. The company’s technologies are incorporated into cinema, television, broadcast, streaming, mobile, personal computer, automotive and gaming products and services.

Its principal offerings include Dolby Atmos, an object-based audio technology designed to create immersive sound, and Dolby Vision, a high-dynamic-range imaging technology intended to improve picture quality.